Breaking News, Financial News

Financial Report: PPD 2Q

Development revenue for the quarter was $333.8 million (+1%). Discovery sciences revenue was $7.7 million, compared to $0.2 million in 2Q09.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PPD 2Q 2Q Revenues: $369.9 million (+4%) 2Q Earnings: $21.0 million (-64%) YTD Revenues: $716.7 million (flat) YTD Earnings: $38.2 million (-62%) Comments: Development revenue for the quarter was $333.8 million (+1%). Discovery sciences revenue was $7.7 million, compared to $0.2 million in 2Q09. Revenue for this segment included a $7.5 million milestone payment from Takeda related to pricing approvals for Nesina (alogliptin) in Japan. Gross authorizations for the quarter totaled $...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters